# A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia

> **NCT04254874** · PHASE4 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 100 (estimated)

## Conditions studied

- 2019-nCoV

## Interventions

- **DRUG:** Abidol hydrochloride
- **DRUG:** Abidol Hydrochloride combined with Interferon atomization

## Key facts

- **NCT ID:** NCT04254874
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04254874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04254874, "A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04254874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*